Patent · US Active

Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors

US9862715B2 · kind B2 · utility

4Cited by

1References

2Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Venkatram Reddy Paidi · Bengaluru, IN
Sreekantha Ratna Kumar · Bengaluru, IN
Abhisek Banerjee · Narayanpur, IN
Ramesh Kumar Sistla · Bengaluru, IN
Satheesh Kesavan Nair · Kanchinakote, IN
William J. Pitts · Newtown, US
John Hynes · Washington Crossing, US

Key dates

Filing date	Dec 7, 2015
Grant date	Jan 9, 2018
Priority date	—
Expiry date	Dec 7, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds having the following formula:or an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein X is N or C—R7, are useful as kinase modulators, including IRAK-4 modulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.